Clinical Trials in Tennessee

Showing 2761-2780 of 20,239 trials

A Study of PHN-010 in Patients With Advanced Solid Tumors

NCT06457997

This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of PHN-010, a novel antibody-drug conjugate (ADC), in patients with advanced solid tumors.

Lung CancerColon CancerEndometrial Cancer+4 more

Pheon Therapeutics26 participantsStarted Jul 2024

Orlando, Florida, United States • Boston, Massachusetts, United States • New York, New York, United States +5 more locations

COMPLETEDPhase 1/229 miles

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

NCT05731947

This study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of revumenib in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.

Colorectal CancerSolid Tumors

Syndax Pharmaceuticals42 participantsStarted Apr 2023

Scottsdale, Arizona, United States • Boston, Massachusetts, United States • Manhattan, New York, United States +3 more locations

A Study of PHN-010 in Patients With Advanced Solid Tumors

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Find Trials by Condition in Tennessee

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

R-3750 in Patients With Mild to Moderate Ulcerative Colitis